← Back to Search

Manual Therapy and Use of the Dynasplint for Trismus in Patients With Head and Neck Cancer

N/A
Waitlist Available
Led By Margaret McNeely, PhD
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights
No Placebo-Only Group

Summary

The objectives of this pilot study are to determine the effectiveness of a manual therapy (MT) protocol plus the use of a dynamic jaw opening device on the maximal interincisor distance; on trismus symptoms; on pain-disability outcomes and on the quality of life, anxiety, and depression in subjects with trismus. The proposed pilot study will comprise a single subject design with multiple baseline measures and during treatment phases to determine the effectiveness of the treatment protocol. A minimum sample of 10 subjects will be recruited. The Health Research Ethics Board of Alberta Cancer Committee will approve this study. Participants will receive a MT protocol plus exercises and the use of the DTS device for 8 weeks. The first two weeks of treatment will involve only MT and opening exercises.After this initial 2 weeks, the DTS will be introduced. The participants will receive a session of 30-45 minutes of MT three/two times per week, for 8 weeks. All participants will be instructed how to use the Dynasplint® Trismus System at home. Analyses: Visual analyses will be performed on participant before, during, and after the intervention. The 2-standard deviation band method will be used to analyze the behavior of each participant on the outcome of interest before, during, and after the treatment. The minimally important difference levels in order to determine clinical relevance will be done. Two effect size indexes will be used: the percentage of non-overlapping data, and the percentage of improvement rate difference.

Eligible Conditions
  • Trismus
  • Cancer
  • Lockjaw

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Minimal Inter-incisor Opening
Secondary study objectives
Adherence to protocol
Global Rating Scale
Gothenburg Trismus Questionnaire
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Physical therapy and dynasplintExperimental Treatment1 Intervention
Participants with trismus will receive a manual therapy protocol plus exercises and the use of the dynasplint (DTS) device for a duration of 8 weeks. The first two weeks of treatment will include 2 days per week of manual therapy and active jaw opening exercises. Following this initial treatment phase, the DTS will be introduced and the frequency of manual therapy will remain at two times per week.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Physical therapy and dynasplint
2018
N/A
~10

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor
942 Previous Clinical Trials
434,399 Total Patients Enrolled
1 Trials studying Trismus
30 Patients Enrolled for Trismus
Cross Cancer InstituteOTHER
61 Previous Clinical Trials
19,209 Total Patients Enrolled
Margaret McNeely, PhDPrincipal InvestigatorUniversity of Alberta
6 Previous Clinical Trials
276 Total Patients Enrolled
1 Trials studying Trismus
30 Patients Enrolled for Trismus
Susan Olivo, PhDPrincipal InvestigatorUniversity of Alberta
~1 spots leftby Jan 2026